What is Percutaneous Coronary Intervention (PCI)?

Percutaneous Coronary Intervention is a minimally invasive catheter-based procedure used to restore blood flow in narrowed or occluded coronary arteries, usually by balloon angioplasty followed by stent implantation.

What are the main indications for PCI?

PCI is indicated in ST-elevation myocardial infarction (primary PCI), high-risk NSTEMI or unstable angina, chronic stable angina with significant ischemia, and selected cases of left main or proximal LAD disease.

Primary PCI refers to immediate PCI performed as the first reperfusion strategy in acute STEMI, ideally within 90–120 minutes of first medical contact.

What is the difference between PCI and coronary angioplasty?

Coronary angioplasty refers only to balloon dilatation of a coronary artery, whereas PCI includes angioplasty plus stent implantation and adjunctive pharmacotherapy.

What are drug-eluting stents (DES)?

Drug-eluting stents are coronary stents coated with antiproliferative drugs that inhibit neointimal hyperplasia, thereby reducing the risk of in-stent restenosis.

Why are drug-eluting stents preferred over bare-metal stents?

Drug-eluting stents significantly reduce restenosis rates compared to bare-metal stents, making them the standard of care in most PCI procedures.

What is dual antiplatelet therapy (DAPT)?

Dual antiplatelet therapy consists of aspirin plus a P2Y12 inhibitor (clopidogrel, prasugrel, or ticagrelor) to prevent stent thrombosis after PCI.

How long should DAPT be continued after PCI?

After PCI with drug-eluting stents, DAPT is recommended for at least 12 months in acute coronary syndrome and at least 6 months in stable coronary artery disease, unless bleeding risk is high.

What are the common access routes for PCI?

The common access routes for PCI are the radial artery and femoral artery, with radial access preferred due to lower bleeding complications.

What is the no-reflow phenomenon in PCI?

No-reflow is a complication where there is inadequate myocardial perfusion despite successful opening of the epicardial coronary artery, usually due to microvascular obstruction.

What are the major complications of PCI?

Major complications include stent thrombosis, coronary dissection or perforation, no-reflow phenomenon, contrast-induced nephropathy, bleeding, and vascular access complications.

What is contrast-induced nephropathy after PCI?

Contrast-induced nephropathy is acute kidney injury occurring after exposure to contrast media during PCI, characterized by a rise in serum creatinine within 48–72 hours.

When is CABG preferred over PCI?

CABG is preferred in patients with diabetes and multivessel disease, left main disease with high SYNTAX score, and complex coronary anatomy unsuitable for PCI.

What is in-stent restenosis?

In-stent restenosis is re-narrowing of a stented coronary segment due to neointimal hyperplasia, typically occurring months after PCI.

What is the most feared late complication of PCI?

Late stent thrombosis is the most feared late complication of PCI because it can lead to sudden myocardial infarction and death.

Percutaneous Coronary Intervention PCI Procedure Indications Steps Complications Management

Percutaneous Coronary Intervention (PCI)

Definition

Percutaneous Coronary Intervention (PCI) is a minimally invasive, catheter-based procedure used to restore blood flow in stenosed or occluded coronary arteries by balloon dilatation and usually stent implantation. It is a cornerstone therapy for coronary artery disease (CAD) and acute coronary syndromes (ACS).

Indications

Acute Indications

ST-Elevation Myocardial Infarction (STEMI) – primary PCI (gold standard)
High-risk Non-STEMI / Unstable Angina
Cardiogenic shock due to ischemia
Ongoing ischemia despite optimal medical therapy

Elective / Chronic Indications

Chronic stable angina with significant ischemia
Prognostically significant lesions:

* Left main disease (selected cases)

* Proximal LAD disease

Failed or contraindicated CABG in selected patients

Contraindications (Relative)

Active bleeding or severe bleeding diathesis
Severe contrast allergy (unless pre-treated)
Advanced renal failure (relative)
Diffuse disease unsuitable for PCI
Poor vascular access

Coronary Anatomy Relevant to PCI

Left Main Coronary Artery (LMCA)
Left Anterior Descending (LAD)
Left Circumflex (LCX)
Right Coronary Artery (RCA)

Lesion complexity assessed by:

SYNTAX score
Lesion length, calcification, tortuosity
Bifurcation involvement
Chronic total occlusion (CTO)

Types of PCI

Based on Clinical Context

Primary PCI – STEMI
Rescue PCI – failed thrombolysis
Elective PCI – stable CAD
Staged PCI – multi-vessel disease

Based on Device

Balloon angioplasty (POBA)
Drug-Eluting Stents (DES) – standard of care
Bare-Metal Stents (BMS) – rarely used
Bioresorbable scaffolds (limited role)

Step-by-Step PCI Procedure

Vascular Access

* Radial artery (preferred)

* Femoral artery (complex cases)

Diagnostic Coronary Angiography

* Defines lesion severity and anatomy

Guide Catheter Placement

* Engages coronary ostium

Guidewire Passage

* Crosses the lesion

Lesion Preparation

* Balloon predilatation

* Cutting/scoring balloon

* Rotational atherectomy (calcified lesions)

Stent Deployment

* DES inflated at high pressure

Post-Dilatation

* Ensures optimal stent expansion

Final Angiographic Assessment

* TIMI flow grade

* Residual stenosis

* Complications

Pharmacotherapy in PCI

Periprocedural Drugs

Antiplatelets

Aspirin

* MOA: COX-1 inhibition → ↓ thromboxane A2

* Loading: 300 mg, Maintenance: 75–150 mg daily

P2Y12 inhibitors

* Clopidogrel (300–600 mg load)

* Prasugrel

* Ticagrelor (preferred in ACS)

Anticoagulants

Unfractionated Heparin
Bivalirudin (selected cases)

GP IIb/IIIa inhibitors (selective use)

Tirofiban, Eptifibatide

Post-PCI Medical Management

Dual Antiplatelet Therapy (DAPT)

DES: minimum 12 months (ACS)
Aspirin + P2Y12 inhibitor

Additional Therapy

High-intensity statin
Beta-blocker
ACE inhibitor / ARB
Lifestyle modification

Complications of PCI

Immediate

Coronary dissection
Acute stent thrombosis
No-reflow phenomenon
Arrhythmias
Access-site bleeding

Early

Contrast-induced nephropathy
Subacute stent thrombosis

Late

In-stent restenosis
Late stent thrombosis

PCI vs CABG (Brief Comparison)

| Feature | PCI | CABG |

| -------------------- | ------------------ | --------------- |

| Invasiveness | Minimally invasive | Open surgery |

| Recovery | Faster | Slower |

| Multi-vessel disease | Limited | Superior |

| Diabetes | Inferior outcomes | Better outcomes |

| Repeat procedures | More common | Less common |

Outcomes & Prognosis

Excellent symptom relief
Reduces mortality in STEMI
Outcome depends on:

* Timely reperfusion

* Complete revascularization

* Adherence to DAPT

Follow-Up After PCI

Regular cardiology review
Monitor for angina recurrence
Lipid profile monitoring
Blood pressure and glucose control
Cardiac rehabilitation

Authoritative External References (Trusted)

American College of Cardiology (ACC):

https://www.acc.org/tools-and-practice-support/clinical-topics/percutaneous-coronary-intervention

European Society of Cardiology (ESC) Guidelines on PCI:

https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines

National Heart, Lung, and Blood Institute (NHLBI):

https://www.nhlbi.nih.gov/health/coronary-angioplasty

Medscape PCI Overview:

https://emedicine.medscape.com/article/161446-overview

UpToDate (Professional Reference):

https://www.uptodate.com/contents/percutaneous-coronary-intervention

Percutaneous Coronary Intervention PCI Procedure Indications Steps Complications Management